1. Resultados e implicaciones del estudio ROCKET;López-Sendón;Rev Esp Cardiol Supl,2013
2. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011
3. European Medicines Agency. Xarelto, Rivaroxaban in atrial fibrillation approval. Sep 22, 2011. Available at: http://www.ema.europa.eu [accessed 23 Apr 2013].
4. US Food and Drug Administration. Xarelto, Rivaroxaban approval. Nov 4, 2011.